نتایج جستجو برای: severe acquired aplastic anemia
تعداد نتایج: 541227 فیلتر نتایج به سال:
BACKGROUND Although the therapeutic outcome of acquired aplastic anemia has improved markedly with the introduction of immunosuppressive therapy using antithymocyte globulin and cyclosporine, a significant proportion of patients subsequently relapse and require second-line therapy. However, detailed analyses of relapses in aplastic anemia children are limited. DESIGN AND METHODS We previously...
Background: Bone marrow failure that results in pancytopenia causes aplastic anemia clinically. Aim: To determine the frequency of positive microRNAs plasma patients with anemia. Study Design: Descriptive cross-sectional study. Methodology: Aplastic were assessed for level and considered if was ≥2 Results: Majority 20(66.7%) aged ≤30 years only 10(33.3%) above 30 years. There 22(73.3%) male 8(2...
Severe aplastic anemia is almost always fatal unless treated. Invasive fungal infections, particularly those caused by Aspergillus species, have long been recognized as a major cause of death in severe aplastic anemia. However, there are few specific reports about infections and their therapy in patients with aplastic anemia. Despite improvements in the last few years, the response rate of new ...
Aplastic Anemia is a rare hematological disorder caused by bone marrow failure leading to pancytopenia. These patients are frequently treated with immunosuppressive therapy which may protect them in developing hyper-inflammatory response commonly seen moderate and severe COVID-19 patients. On the other hand these at high risk for infection related complications. Here we reporting an adult aplas...
BACKGROUND Aplastic anemia is a rare and severe disease. Its incidence varies considerably worldwide. We aimed at describing the epidemiology of this disease, including the incidence, mortality and survival trends, in a well-defined population. DESIGN AND METHODS Since 1980, a case-control surveillance study of aplastic anemia has been carried out by a cooperative group, in the metropolitan a...
The clinical outcome for patients with aplastic anemia (AA) is dependent upon the severity of the pancytopenia and patient age. Allogeneic hematopoietic stem cell transplantation (HSCT) is the best curative treatment for severe and very severe aplastic anemia (SAA) and is the treatment of choice for those less than 50 years of age. The expected five years survivals of patients less than 20 year...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید